On October 19, 2001, Philips Medical Systems completed an acquisition strategy through its purchase of Marconi Medical Systems.
The History of Marconi Medical Systems
2001 Royal Philips Electronics and Marconi plc announced that Philips has agreed to acquire Marconi Medical Systems for $1.1 billion.
2000 Marconi introduces Infinite Detector Technology for Mx8000 multislice CT scanner, which acquires an unprecedented 16 simultaneous slices with sub-millimeter isotropic accuracy.
1999 At RSNA, Picker International unveils the new Marconi Medical Systems name and corporate vision.
1998 Picker International acquires the Computed Tomography Division of Elscint Ltd, immediately positioning Picker at the forefront of major global CT suppliers.
1986 Picker produces the industry's first 1.0T MR imager.
1981 Picker is sold to General Electric Co. Ltd. of England (GEC). Picker merged with Cambridge Instruments, GEC Medical, and American Optical to form Picker International.
1967 The name changed from Picker x-ray to Picker Corporation. Picker acquired Dunlee.
1946 The Dunlee Corporation started in Chicago by Dunmore Dunk and Zed. J. Atlee to meet demand for quality x-ray tubes and special purpose tubes.
1915 James Picker Company formed in New York City offering sales and service of x-ray equipment, film and accessories.

(mA): 10^-3 ampere. In radiography, the current flow from the cathode to the anode in the x-ray tube is measured in milliampere. This current regulates the radiation intensity emitted by the x-ray tube.

See X-Ray Tube.

(MPI) The myocardial perfusion scan is the most common nuclear medicine procedure in cardiac imaging and allows assessing the blood-flow patterns to the heart muscles. The comparison of the radiopharmaceutical distribution after stress and at rest provides information on myocardial viability and cardiac perfusion abnormalities. ECG-gated myocardial perfusion imaging allows the assessment of global and regional myocardial function such as wall motion abnormalities.
The diagnostic accuracy of myocardial perfusion scintigraphy (also abbreviated MPS) allows reliable risk stratification and guides the selection of patients for further interventions, such as revascularization. MPI also has particular advantages over alternative techniques in the management of a number of patient subgroups, including women, the elderly, and those with diabetes. The use of this type of cardiac scintigraphy is associated with greater cost effectiveness of treatment, in terms of life-years saved, particularly in these special patient groups.
Myocardial perfusion scintigrams are acquired with a gamma camera. Single photon emission computed tomography (SPECT) is preferred over planar imaging because of the three dimensional nature of the images and their superior contrast resolution.
Common MPI radiopharmaceuticals, approved by the U.S. Food and Drug Administration (FDA) include: Tl-201 and the Tc-99m-labeled radiopharmaceuticals, such as sestamibi, tetrofosmin, and teboroxime for single-photon imaging. Rb-82 is used for positron emission tomography (PET) imaging.

See also Gated Blood Pool Scintigraphy, Myocardial Late Enhancement, Cardiac MRI and Echocardiography.

This elementary particle was already proposed in 1930 by Wolfgang Pauli and in 1934 by Enrico Fermi , and gets detected experimentally by Clyde Cowan and Fred Reines in 1956. In addition to the electron-, antielectron-neutrino the discovery of the muon-, antimuon-neutrino in 1962 and the tau-, antitau-neutrino in 2000 followed.
Neutrinos have no charge, a very small mass and interact rarely with matter, which make them difficult to detect. During beta decay, a neutron converts into a proton, an electron and an antineutrino, which is emitted. Some of today's Research projects try to find out the concrete mass of neutrinos or if neutrinos can change from one neutrino type to another.

A sample is placed into a concentrated beam of neutrons. Through neutron-capture heavier nuclei become frequently unstable. This artificial radiation decays with a characteristic half-live consisting of alpha- and beta-particles and gamma-rays.

See Neutron Activation Analysis